U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 15:23:57 GMT 2023
Edited
by admin
on Sat Dec 16 15:23:57 GMT 2023
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|TOXIN CONJUGATE
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
W95G28K44S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Trastuzumab Vedotin
INN  
Official Name English
Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody; conjugated to auristatin E
Common Name English
MRG 002 [WHO-DD]
Common Name English
TRASTUZUMAB--VCMMAE CONJUGATE
Common Name English
MRG002
Code English
trastuzumab vedotin [INN]
Common Name English
Gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (217) (121-218), hinge 1-15
Common Name English
MRG-002
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 898822
Created by admin on Sat Dec 16 15:23:58 GMT 2023 , Edited by admin on Sat Dec 16 15:23:58 GMT 2023
Code System Code Type Description
INN
12531
Created by admin on Sat Dec 16 15:23:58 GMT 2023 , Edited by admin on Sat Dec 16 15:23:58 GMT 2023
PRIMARY
NCI_THESAURUS
C174205
Created by admin on Sat Dec 16 15:23:58 GMT 2023 , Edited by admin on Sat Dec 16 15:23:58 GMT 2023
PRIMARY
CAS
2740607-04-7
Created by admin on Sat Dec 16 15:23:58 GMT 2023 , Edited by admin on Sat Dec 16 15:23:58 GMT 2023
PRIMARY
FDA UNII
W95G28K44S
Created by admin on Sat Dec 16 15:23:58 GMT 2023 , Edited by admin on Sat Dec 16 15:23:58 GMT 2023
PRIMARY
From To
4_134 4_194
4_23 4_88
3_134 3_194
3_23 3_88
2_370 2_428
2_264 2_324
2_223 4_214
2_147 2_203
2_22 2_96
1_370 1_428
1_264 1_324
1_232 2_232
1_229 2_229
1_223 3_214
1_147 1_203
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
CONJUGATE COMPONENT->CONJUGATE
CONJUGATE COMPONENT->CONJUGATE
CONJUGATE COMPONENT->CONJUGATE
TARGET->CONJUGATED TOXIN
MRG002 potently inhibited proliferation of HER2 expressing cancer cells in vitro with IC50 ranged from 1.8±0.8 to 59.9±8.9 ng/mL,
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL